These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 27498826

  • 1. Comparison of the live-attenuated Japanese encephalitis vaccine SA14-14-2 strain with its pre-attenuated virulent parent SA14 strain: similarities and differences in vitro and in vivo.
    Yun SI, Song BH, Polejaeva IA, Davies CJ, White KL, Lee YM.
    J Gen Virol; 2016 Oct; 97(10):2575-2591. PubMed ID: 27498826
    [Abstract] [Full Text] [Related]

  • 2. A molecularly cloned, live-attenuated japanese encephalitis vaccine SA14-14-2 virus: a conserved single amino acid in the ij Hairpin of the Viral E glycoprotein determines neurovirulence in mice.
    Yun SI, Song BH, Kim JK, Yun GN, Lee EY, Li L, Kuhn RJ, Rossmann MG, Morrey JD, Lee YM.
    PLoS Pathog; 2014 Jul; 10(7):e1004290. PubMed ID: 25077483
    [Abstract] [Full Text] [Related]

  • 3. The A66G back mutation in NS2A of JEV SA14-14-2 strain contributes to production of NS1' protein and the secreted NS1' can be used for diagnostic biomarker for virulent virus infection.
    Wang J, Li X, Gu J, Fan Y, Zhao P, Cao R, Chen P.
    Infect Genet Evol; 2015 Dec; 36():116-125. PubMed ID: 26384477
    [Abstract] [Full Text] [Related]

  • 4. Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities.
    Yu Y.
    Vaccine; 2010 May 07; 28(21):3635-41. PubMed ID: 20226891
    [Abstract] [Full Text] [Related]

  • 5. A single nucleotide mutation in NS2A of Japanese encephalitis-live vaccine virus (SA14-14-2) ablates NS1' formation and contributes to attenuation.
    Ye Q, Li XF, Zhao H, Li SH, Deng YQ, Cao RY, Song KY, Wang HJ, Hua RH, Yu YX, Zhou X, Qin ED, Qin CF.
    J Gen Virol; 2012 Sep 07; 93(Pt 9):1959-1964. PubMed ID: 22739060
    [Abstract] [Full Text] [Related]

  • 6. Genetic Determinants of Japanese Encephalitis Virus Vaccine Strain SA14-14-2 That Govern Attenuation of Virulence in Mice.
    Gromowski GD, Firestone CY, Whitehead SS.
    J Virol; 2015 Jun 07; 89(12):6328-37. PubMed ID: 25855730
    [Abstract] [Full Text] [Related]

  • 7. Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE).
    Arroyo J, Guirakhoo F, Fenner S, Zhang ZX, Monath TP, Chambers TJ.
    J Virol; 2001 Jan 07; 75(2):934-42. PubMed ID: 11134306
    [Abstract] [Full Text] [Related]

  • 8. Genetic and neuroattenuation phenotypic characteristics and their stabilities of SA14-14-2 vaccine seed virus.
    Liu X, Zhao D, Jia L, Xu H, Na R, Ge Y, Liu S, Yu Y, Li Y.
    Vaccine; 2018 Jul 25; 36(31):4650-4656. PubMed ID: 29954631
    [Abstract] [Full Text] [Related]

  • 9. Envelope protein gene based molecular characterization of Japanese encephalitis virus clinical isolates from West Bengal, India: a comparative approach with respect to SA14-14-2 live attenuated vaccine strain.
    Sarkar A, Banik A, Pathak BK, Mukhopadhyay SK, Chatterjee S.
    BMC Infect Dis; 2013 Aug 08; 13():368. PubMed ID: 23927571
    [Abstract] [Full Text] [Related]

  • 10. Biological and genetic properties of SA₁₄-14-2, a live-attenuated Japanese encephalitis vaccine that is currently available for humans.
    Song BH, Yun GN, Kim JK, Yun SI, Lee YM.
    J Microbiol; 2012 Aug 08; 50(4):698-706. PubMed ID: 22923123
    [Abstract] [Full Text] [Related]

  • 11. A novel amino acid site closely associated with the neurovirulence of live, attenuated Japanese encephalitis vaccine (SA14-14-2 strain).
    Yang H, Fan F, Liu L, Liu J, Sun Y, Xie A, Shi X, Liu L, Yu Y, Li Y, Ge Y, Zeng X, Yang H.
    Vaccine; 2020 Mar 04; 38(11):2636-2642. PubMed ID: 32044162
    [Abstract] [Full Text] [Related]

  • 12. Genotype-specific neutralization determinants in envelope protein: implications for the improvement of Japanese encephalitis vaccine.
    Ye Q, Xu YP, Zhang Y, Li XF, Wang HJ, Liu ZY, Li SH, Liu L, Zhao H, Nian QG, Deng YQ, Qin ED, Qin CF.
    J Gen Virol; 2015 Aug 04; 96(8):2165-2175. PubMed ID: 25908779
    [Abstract] [Full Text] [Related]

  • 13. Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates.
    Monath TP, Soike K, Levenbook I, Zhang ZX, Arroyo J, Delagrave S, Myers G, Barrett AD, Shope RE, Ratterree M, Chambers TJ, Guirakhoo F.
    Vaccine; 1999 Apr 09; 17(15-16):1869-82. PubMed ID: 10217584
    [Abstract] [Full Text] [Related]

  • 14. Characterization of live-attenuated Japanese encephalitis vaccine virus SA14-14-2.
    Yang D, Li XF, Ye Q, Wang HJ, Deng YQ, Zhu SY, Zhang Y, Li SH, Qin CF.
    Vaccine; 2014 May 13; 32(23):2675-81. PubMed ID: 24709585
    [Abstract] [Full Text] [Related]

  • 15. The structure differences of Japanese encephalitis virus SA14 and SA14-14-2 E proteins elucidate the virulence attenuation mechanism.
    Liu X, Zhao X, Na R, Li L, Warkentin E, Witt J, Lu X, Yu Y, Wei Y, Peng G, Li Y, Wang J.
    Protein Cell; 2019 Feb 13; 10(2):149-153. PubMed ID: 29752689
    [No Abstract] [Full Text] [Related]

  • 16. [Construction of infectious Japanese encephalitis virus clone based on the cDNA template of the attenuated live vaccine production strain SA14-14-2].
    Zeng M, Jia LL, Yu YX, Dong GM, Liu WX, Wang ZW, Li DF.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Mar 13; 19(1):9-11. PubMed ID: 16201461
    [Abstract] [Full Text] [Related]

  • 17. Sero-Molecular Epidemiology of Japanese Encephalitis in Zhejiang, an Eastern Province of China.
    Pan JR, Yan JY, Zhou JY, Tang XW, He HQ, Xie RH, Mao HY, Zhang YJ, Xie SY.
    PLoS Negl Trop Dis; 2016 Aug 13; 10(8):e0004936. PubMed ID: 27560360
    [Abstract] [Full Text] [Related]

  • 18. Enhanced cytopathic effect of Japanese encephalitis virus strain SA14-14-2: Probable association of mutation in amino acid of its envelope protein.
    Nath B, Gupta A, Khan SA, Kumar S.
    Microb Pathog; 2017 Oct 13; 111():187-192. PubMed ID: 28867626
    [Abstract] [Full Text] [Related]

  • 19. Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose-response effectiveness and extended safety testing in rhesus monkeys.
    Monath TP, Levenbook I, Soike K, Zhang ZX, Ratterree M, Draper K, Barrett AD, Nichols R, Weltzin R, Arroyo J, Guirakhoo F.
    J Virol; 2000 Feb 13; 74(4):1742-51. PubMed ID: 10644345
    [Abstract] [Full Text] [Related]

  • 20. Envelope Protein Mutations L107F and E138K Are Important for Neurovirulence Attenuation for Japanese Encephalitis Virus SA14-14-2 Strain.
    Yang J, Yang H, Li Z, Wang W, Lin H, Liu L, Ni Q, Liu X, Zeng X, Wu Y, Li Y.
    Viruses; 2017 Jan 21; 9(1):. PubMed ID: 28117725
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.